ESC Premium Access

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy (DAPT) Study

Congress Presentation

About the speaker

Doctor Charles Resor

Brigham and Women's Hospital, Boston (United States of America)
1 presentation
0 follower

5 more presentations in this session

Prevention of First Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54

Speaker: Doctor M. Bonaca (Aurora, US)


The Italic/Italic Plus Trial

Speaker: Professor M. Gilard (Brest, FR)


PCI for Elderly patients at High Bleeding Risk. A substudy of the LEADERS FREE trial

Speaker: Doctor M. Morice (Massy, FR)


Ten-year outcomes of first-generation drug-eluting stents results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization (SIRTAX) VERY LATE Trial

Speaker: Professor L. Raber (Bern, CH)


Ad-hoc versus non-ad-hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease.

Speaker: Doctor T. Toyota (Kobe, JP)


Access the full session

Clinical Trial Update Platelet therapy

Speakers: Doctor C. Resor, Doctor M. Bonaca, Professor M. Gilard, Doctor M. Morice, Professor L. Raber...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb